Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1997;4(6):305–306. doi: 10.1155/MBD.1997.305

Antitumor Activity of the Carboplatin-α-Cyclodextrin Adduct

Weiping Liu 1,✉, Huizhou Xiong 1, Yikun Yang 1, Ling Li 2, Zhiqiang Shen 2, Zhihe Chen 2
PMCID: PMC2365085  PMID: 18475810

Abstract

Antitumor activity of the adduct between Carboplatin and α-cyclodextrin has been tested against Sarcoma 180 (S180) and Ehrlich ascites carcinoma (EAC) murine tumors. The preliminary toxicity has also been evaluated by histological examinations of the treated animals. The results show the adduct has less antitumor efficacy than and similar toxicity to Carboplatin.

Full Text

The Full Text of this article is available as a PDF (230.1 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES